Belvedere Trading LLC Reata Pharmaceuticals Inc Call Options Transaction History

Belvedere Trading LLC

  • $74.4 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 08, 2023
SELL
$79.22 - $105.37 $213,894 - $284,499
-2,700 Reduced 50.94%
2,600 $265,000
Q1 2023

May 15, 2023
BUY
$30.85 - $93.17 $86,380 - $260,876
2,800 Added 112.0%
5,300 $481,000
Q4 2022

Feb 14, 2023
BUY
$22.15 - $42.11 $55,375 - $105,275
2,500 New
2,500 $94,000
Q1 2022

Apr 20, 2022
BUY
$24.12 - $39.6 $267,732 - $439,560
11,100 New
11,100 $350,000

Others Institutions Holding RETA

# of Institutions
5
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About REATA PHARMACEUTICALS INC

RETA Quotes by TradingView
  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email